These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 12107841

  • 1. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL, Yoon KA, Kim IJ, Kim WH, Jang JY, Suh KS, Kim SW, Park YH, Hwang JH, Yoon YB, Park JG.
    Br J Cancer; 2002 Jul 15; 87(2):187-93. PubMed ID: 12107841
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F.
    Int J Cancer; 2002 Feb 01; 97(4):481-8. PubMed ID: 11802210
    [Abstract] [Full Text] [Related]

  • 3. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, Kanai T, Saya H, Arima Y.
    Cancer Sci; 2021 May 01; 112(5):1822-1838. PubMed ID: 33068050
    [Abstract] [Full Text] [Related]

  • 4. Cellular and molecular biology of biliary tract cancers.
    Rashid A.
    Surg Oncol Clin N Am; 2002 Oct 01; 11(4):995-1009. PubMed ID: 12607585
    [Abstract] [Full Text] [Related]

  • 5. Establishment and characterization of 12 human colorectal-carcinoma cell lines.
    Oh JH, Ku JL, Yoon KA, Kwon HJ, Kim WH, Park HS, Yeo KS, Song SY, Chung JK, Park JG.
    Int J Cancer; 1999 Jun 11; 81(6):902-10. PubMed ID: 10362137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.
    Kim SG, Chan AO, Wu TT, Issa JP, Hamilton SR, Rashid A.
    Gastroenterology; 2003 May 11; 124(5):1300-10. PubMed ID: 12730870
    [Abstract] [Full Text] [Related]

  • 8. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May 11; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 9. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A.
    J Pathol; 2005 Jul 11; 206(3):356-65. PubMed ID: 15892172
    [Abstract] [Full Text] [Related]

  • 10. Analysis of microsatellite instability, TGF-beta type II receptor gene mutations and hMSH2 and hMLH1 allele losses in pancreaticobiliary maljunction-associated biliary tract tumors.
    Nagai M, Kawarada Y, Watanabe M, Iwase T, Muneyuki T, Yamao K, Fukutome K, Yatani R.
    Anticancer Res; 1999 Jul 11; 19(3A):1765-8. PubMed ID: 10470113
    [Abstract] [Full Text] [Related]

  • 11. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
    Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE.
    Cancer Res; 1998 Dec 01; 58(23):5329-32. PubMed ID: 9850059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
    Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT.
    Hum Pathol; 2003 Sep 01; 34(9):902-10. PubMed ID: 14562286
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC, Lee KT, Tsai KB, Sheen PC, Nagai E, Mizumoto K, Tanaka M.
    World J Surg; 2004 Oct 01; 28(10):995-1000. PubMed ID: 15573254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S.
    Pancreas; 2004 Oct 01; 29(3):193-203. PubMed ID: 15367885
    [Abstract] [Full Text] [Related]

  • 17. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.
    Yoon JG, Kim MH, Jang M, Kim H, Hwang HK, Kang CM, Lee WJ, Kang B, Lee CK, Lee MG, Chung HC, Choi HJ, Park YN.
    Hepatology; 2021 Oct 01; 74(4):1914-1931. PubMed ID: 33884649
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
    Viswanathan M, Tsuchida N, Shanmugam G.
    Int J Cancer; 2003 May 20; 105(1):41-6. PubMed ID: 12672028
    [Abstract] [Full Text] [Related]

  • 19. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF.
    Leuk Res; 2003 Jan 20; 27(1):23-34. PubMed ID: 12479849
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of seven human renal cell carcinoma cell lines.
    Shin KH, Ku JL, Kim WH, Lee SE, Lee C, Kim SW, Park JG.
    BJU Int; 2000 Jan 20; 85(1):130-8. PubMed ID: 10619961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.